The epithelial to mensenchymal transition program regulates various areas of embryonic development and tissue homeostasis, but aberrant activation of this pathway in cancer contributes to tumor progression and metastasis. Introduction The epithelial to mesenchymal transition (EMT) program is usually a reversible process important during embryonic development and tissue homeostasis by controlling the formation of the body plan and tissue and organ differentiation [1]. Deregulation of EMT through incorrect or excessive activation can also result in Dovitinib Dilactic acid adverse effects by inducing fibrosis and malignancy progression [1]. Induction of EMT evokes a change from a polarized epithelial phenotype, in which cells are adherent to the basement membrane and express classical epithelial makers including E-cadherin and ZO-1, to a mesenchymal state in which cell-cell contact is certainly dropped and mesenchymal manufacturers are expressed such as for example N-cadherin and Vimentin [2], [3]. TGF- is certainly a powerful inducer of EMT in a multitude of individual malignancies of epithelial origins. The EMT induced mesenchymal phenotype in epithelial cancers types is certainly connected with elevated migratory and intrusive properties, basement membrane degradation, resistance to apoptosis and malignancy stem cell characteristics, which ultimately results in increased metastasis, therapy resistance and poor-prognosis in malignancy patients [2], [3], [4]. TGF–induced EMT is usually mediated by both the canonical Smad2/3 dependent pathway and the non-canonical Smad2/3-impartial pathway which includes the MAPK and PI-3K/PKB signaling routes [5]. The phenotypic changes observed during TGF–induced EMT are exerted through alterations in the expression of a variety of transcriptional regulators, including Snail, Slug, Twist, Goosecoid, zinc-finger E-box binding homeobox 1 (ZEB1) and FOXC2 [4]. Most of these transcription factors are transcriptional repressors involved in the direct or Dovitinib Dilactic acid indirect down-regulation of E-cadherin expression and a reduction in the epithelial phenotype. In contrast, the TGF–mediated induction of a mesenchymal phenotype during EMT appears to Mmp2 be controlled by transcriptional activators. For example, TGF–mediated induction of the transcription factor FOXC2 has been shown to be required for the increased expression of mesenchymal markers such as N-cadherin, vimentin and fibronectin [6], [7]. However, ectopic expression of FOXC2 in epithelial cells is usually insufficient to induce a full EMT phenotype resulting in increased expression of mesenchymal markers, but lacking total repression of E-cadherin and other epithelial markers [7]. In this study we investigated the potential role of additional transcriptional activators in the context of TGF–induced EMT in breast cancer. Here, we identify SOX4 as a transcriptional activator of which both the expression and transcriptional activity are induced by TGF- in human mammary epithelial cells (HMECs) during EMT. Conditional activation of SOX4 in non-transformed immortalized HMEC expressing hTERT and SV40 large T and small t antigens (HMLE) was sufficient to drive the expression mesenchymal markers, such as N-cadherin, without affecting expression of the epithelial markers Dovitinib Dilactic acid E-cadherin and -Catenin. Finally, we demonstrate that SOX4 expression is necessary for TGF–mediated induction of N-cadherin during EMT. Taken together, these data identify SOX4 as a novel transcriptional activator involved in the transcriptional response regulating mesenchymal gene expression during TGF–induced EMT. Materials and Methods Cell Culture Non-transformed Human mammary epithelial cells (classified as HMLE hTERT and kindly provided by Dr. Robert Weinberg) were cultured in MEGM medium (Lonza, Basel, Switzerland): F12 media (Invitrogen, Oregon, USA) (11) supplemented with insulin (Lonza), EGF (Lonza), hydrocortisone (Lonza), penicillin-streptomycin (Invitrogen, Oregon, USA) (Weinberg et al, 2008). Mesenchymal-like phenotype cell cultures were obtained by supplementing the normal culture medium with 2.5 ng/ml of TGF-1 (Sigma-Aldrich-Aldrich, Missouri, USA). HEK293T cells (derived from human embryonic kidney) were managed in DNEM (Invitrogen) supplemented with 8% heat-inactivated FBS and penicillin-streptomycin (Invitrogen). Generation of a Sox4 Cell Lines To generate a conditionally regulated Sox4 (ER:Sox4), the sequence of the mouse Sox4 gene was fused in frame with to the hormone-binding domain name of the human estrogen receptor (ER). The ER:Sox4 or ER construct was subcloned into the polylinker region of Dovitinib Dilactic acid the pBABE vector which contains an internal ribosomal access site followed by the gene encoding for puromycin resistance. pBABE-puro retrovirus was produced by stable transfection of the retroviral packaging cell collection, Phoenix-ampho, by calcium phosphate coprecipitation..